Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status: Completed

Conditions: Drug-Related Side Effects and Adverse Reactions; Carcinoma, Non-Small-Cell Lung

Treatments: Other: Consultation of the patient's medical files at the hospital

Study type: Observational

Funder types: Other

Identifiers

NCT03125603

2017/15MAR/137

Details and patient eligibility

About

The immune-related adverse events (irAEs) linked to the important activation of the immune system by new immunotherapy treatments in patients affected by Non-small-cell lung carcinoma (NSCLC) have not received a lot of systematic study or been monitored over time outside of clinical trials.

This study aims to verify, on the basis of the data collected in a prospective and retrospective manner, that the side-effects due of anti-PD-(L)-1 or anti-CTLA-4 treatments observed in the target population of the controlled clinical trials are the same as in the general clinical population.

Enrollment: 80 patients

Sex: All

Ages: 20 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any patient with NSCLC treated in Cliniques Universitaires Saint-Luc with immunotherapy in first or second line.

Exclusion criteria

• The refusal to sign the consent.

Trial design

80 participants in 1 patient group

NSCLC's patients

Description:

Patients with NSCLC treated in Cliniques Universitaires Saint-Luc with immunotherapy. Consultation of the patient's medical files at the hospital.

Treatment:

Other: Consultation of the patient's medical files at the hospital